트렌스젠바이오

트렌스젠바이오 is a declared insider of 엠젠솔루션, with filings sourced from DART (FSS). Over a trading history stretching from 30 March 2021 to 29 June 2026, the count stands at 26 filings.

Market trades split into 19 purchases and 4 sales. The totals do not cover 23 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at no purchases and 2 sales.

Across 19 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 29 June 2026 with an open-market sale in 엠젠솔루션. The latest purchase dates back some time: it was published 839 days ago, on 1 July 2024. The median gap between a trade and its publication by DART (FSS) is 7 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.